EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57

Abstract

AN ATTEMPT TO DECIPHER THE AMBIGUITIES OF INCREASED SIX MONTHS HOSPITAL READMISSION IN HEART FAILURE PATIENTS

Ashraf Shaat, MD, Amal Zakout, MD2, Khaled Alkhodari, MD and Mohammed Habib, MD, PHD

ABSTRACT

Background: Heart failure (HF) has high in-hospital mortality and is associated with high readmission rates. Reasons for and ways to avoid HF readmissions are unclear. Approximately one-third of patients admitted for HF are readmitted within 6 months. We still desperately need to know some of the independent variables that would define high-risk groups of HF patients for re-hospitalization. Methods and Results: This is a prospective, observational study enrolled patients with ejection fraction (EF) <40%, were admitted because of acute decompensation. Out of the total 164 patients 63% were male. The mean age of the study population was 65.79 ±14.118. Male vs female, living at home independently and self -pay were statistically significant in the readmitted group (P=0.042, 0.007, 0.001). Co morbidity and clinical finding which showed significance increase with readmission include; hypertension(P=0.013), Acute coronary syndrome (P=0.015), mitral regurgitation (P=0.002), aortic regurgitation (P=0.014), LBBB (P=0.048), Urosepsis (P=0.008), and EF (P=0.041). Parameters on logistic regression analysis anemia (OR,1.7; CI,0.8-3.4), hypertension (OR,2.5; CI,1.2-5.4), ejection fraction less than 30% (OR, 1.9; CI, 0.9-3.7), mitral regurgitation (OR, 2.8; CI, 1.4-5.6), hyponatremia (OR,2.0. CI, 0.5-7.6), and high creatinine (OR, 1.3; CI,0.6-2.8) were independently increased the risk of rehospitalization at six months of discharge. Conclusion: Rehospitalization rate was 33%. Higher rates of readmission were noted in those with older male, hypertensive patients, low EF, mitral regurgitation, impaired kidney function, anemia, hyponatremia, living at home independently and infections.

Keywords: Heart failure, Anemia, hospital readmission.


[Full Text Article]

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 November 2020 Issue has been Published, Kindly check it on http://www.ejpmr.com/home/current_issues

  • EJPMR NOVEMBER ISSUE PUBLISHED

    NOVEMBER 2020 Issue has been successfully launched on 1 November 2020.

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing